Backgroud: Neuroblastoma (NB) tumor rupture is a rare oncology emergency with poor prognosis. We aimed to evaluate clinical characteristics and risk factors for ruptured NB.
3 presentation among NB patients, and several studies have reported poor prognosis of patients with ruptured NB [2] . Some patients are diagnosed with NB following spontaneous tumor rupture as the initial presentation. However, accurate diagnosis may be difficult if a tumor is ruptured at initial presentation. In addition, some cases develop tumor rupture during or after chemotherapy and biopsy. Several treatment modalities, including symptomatic supportive therapy, emergency or staged surgery, and chemotherapy, have been described. In this study, we retrospectively evaluated the clinical characteristics, treatment, and prognosis of ruptured NB cases. Moreover, to identify clinical risk factors for tumor rupture among NB patients, we compared clinical characteristics between nonruptured and ruptured NB. Thus, our goal was to contribute to current knowledge of this rare disease and improve pre-existing treatment strategies.
Methods

Patient information
A total of 47 consecutive patients with ruptured NB who were diagnosed in Beijing Children's Hospital (BCH) between January 2009 and January 2019 were included in this retrospective study. To compare the clinical characteristics between nonruptured and ruptured high-risk NB, we included 93 consecutive patients with nonruptured high-risk NB in the abdomen and pelvis from January 2017 to January 2019 in this retrospective study.
Medical records were referred to obtain basic patient information. The initial diagnosis of NB was given according to the International Neuroblastoma Staging System (INSS) criteria [3] . In special cases of seriously ill patients without bone marrow metastasis, the initial clinical diagnosis was established by typical tumor localization with typical metastases (such as bone, liver, lymph node, and skin) detected by metaiodobenzylguanidine (MIBG) or fluorine-18-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography ( 18 F-FDG PET/CT) and combined with abnormal tumor marker levels. Patients were staged according to the International Neuroblastoma Risk Group Staging System (INRGSS) [4] and grouped by the INRG classification system [5] . Patients with ruptured NB were followed up to January 1, 2019. All methods were carried out in accordance with relevant guidelines and regulations, and the study was approved by the Medical Ethics Committee of BCH (2017-k-89). A waiver of consent was awarded to conduct analyses in this study.
Laboratory analysis
Laboratory analysis was performed prior to treatment, and the interval between laboratory tests and biopsy was less than 15 days. Urinary vanillylmandelic acid (VMA) and homovanillic acid (HVA) were analyzed by gas chromatography-mass spectrometry (GC/MS), and their concentrations were expressed as a ratio to urinary creatinine concentration. Lactate dehydrogenase (LDH), neuron-specific enolase (NSE), and ferritin were measured in serum using routine clinical chemistry laboratory methods. Bone marrow metastasis disease was evaluated by bone marrow aspiration and biopsy. Tumors were classified in accordance with the International Neuroblastoma Pathology Classification System (INPC) [6] . In this study, MYCN gene copy numbers and segmental chromosome aberration (1p and 11q) were analyzed using the fluorescence in situ hybridization (FISH) method.
Treatment
Patients were treated with multimodal therapy based on the BCH-NB-2007 protocol for intermediate-risk NB combined with chemotherapy and surgery [7] . According to the biological features of the tumor, patients received four or eight cycles of chemotherapy.
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Chemotherapy consisted of reduced doses of carboplatin and etoposide (CBVP) and cyclophosphamide, adriamycin and vincristine (CADO). In the BCH-NB-2007 protocol for high-risk NB (based on the Hong Kong N6 protocol), chemotherapy, surgery, and myeloablative therapy (carboplatin, etoposide and melphalan) were performed with autologous stem cell rescue, radiotherapy, and treatment of minimal residual disease with isotretinoin. Induction chemotherapy consisted of high-dose cyclophosphamide, adriamycin and vincristine (CAV) and high-dose cisplatinum and etoposide (CVP).
Chemotherapy was performed every 21 days. Surgical resection of residual primary tumor or sites of regional dissemination (nodal disease) was performed after cycle 4, and peripheral-blood stem cell harvest was performed after cycle 5.
Statistical analysis
Statistical analysis was performed by SAS 9.4. Continuous variables were presented as the mean with standard deviation or median and interquartile range if the normality hypothesis test rejected the null hypothesis of normal distribution. Categorical variables were reported as counts and percentages. Two independent samples t-tests and c 2 tests were used to compare characteristics between the ruptured and nonruptured groups.
Receiver operating characteristic (ROC) curve analysis was performed to determine the most appropriate cut-off values. Univariate and multivariate logistic regression analyses were conducted to select potentially useful characteristics for predicting tumor rupture.
The area under the receiver operating characteristic (AUC-ROC) curves of the model were calculated (in this study, some tumor marker results were obtained after tumor rupture as some patients were admitted to the hospital with spontaneous tumor rupture. Thus, the tumor marker results were not included in the analysis). P < 0.05 was considered statistically significant. 6 
Results
Patient characteristics
During the study period from January 2009 to January 2019, NB was diagnosed in approximately 1800 patients at our institute. A total of 47 ruptured NB patients (28 male and 19 female), with a median age at presentation of 29 months (range, 6 months to 8 years), were included in this study. Table 1 died (13 patients died of tumor recurrence or progression, and one died of renal failure after surgery) with a median time of 11 (7, 21) months (range, 2 months to 37 months).
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In this study, 14 patients experienced tumor recurrence or progression, with a median time of 10 (6, 15) months (range, 2 months to 22 months) after diagnosis. Seven patients experienced tumor progression during therapy and died (4 cases of local progression and 3 cases of combined local and distant metastatic progression). Alternatively, 7 patients experienced tumor recurrence (4 cases of local recurrence, one case of distant metastatic recurrence, and 2 cases of combined local and distant metastatic recurrence), and 6 of these patients died. Only one patient survived for 46 months after chemotherapy and tumor resection.
Tumor rupture risk factors
Since NB tumor rupture mainly occurs in children with high-risk NB (40/42, 95.24%), we further analyzed 93 cases of INRG high-risk NB patients with primary nonruptured tumors in this study. By comparing the clinical characteristics between nonruptured (n = 93) and ruptured (n = 40) high-risk NB ( Table 2) , we found significant differences in age, primary site, maximum diameter of the primary tumor, most tumor markers, pathological characteristics, and the MYCN gene (P < 0.05).
In this study, some tumor marker results were obtained after tumor rupture as some patients were admitted to the hospital with spontaneous tumor rupture. Thus, the tumor marker results were not included in multivariate analysis. And then, the age, primary site, maximum diameter of the primary tumor, pathological characteristics (INPC categories, MKI, INPC), and the MYCN gene were included in the multivariate logistic regression analysis. According to the maximum joint sensitivity and specificity values, the stratification value of age and maximum diameter of the primary tumor were calculated by ROC curve analyses. The cut-off values for the above characteristics were 29 months and 13.2 cm, respectively ( Supplementary Figure 1) .
In multivariate logistic regression analysis, the maximum diameter of primary tumor > 13.20 cm and MYCN gene amplification were two independent risk factors for high-risk NB tumor rupture, with adjusted odds ratios (ORs) of 6.401 (1.986, 20 .626) and 7.874 (2.520, 24.603), respectively (Supplementary Table 1 ). The AUC-ROC of the model was 0.827, and the sensitivity and specificity were 96.2% (95% Confidence Interval: 78.4% -99.8%) and 66.2% (95% Confidence Interval: 53.3% -77.1%), respectively (Supplementary Figure 2 ). Table 1 and Spontaneous NB rupture is very rare in infants or children. This condition is more common in neonates, which can be explained by the trauma of delivery, especially when a congenital adrenal mass is crushed between the spine and liver [8] [9] [10] . Generally, the mechanism of spontaneous NB rupture is not fully understood. In terms of anatomic position, neonatal adrenal NB, which originates from the right side and is located between the spine and liver, is more prone to rupture [1, 11] . Regarding tumor size, a larger tumor is more likely to rupture. In a previous report, the risk of rupture significantly increased when the maximum diameter of the tumor exceeded 10 cm [12, 13] . Regarding tumor components, tumors with solid components are less likely to rupture, while tumors with obvious cystic components and liquefaction necrosis are more likely to rupture. With regard to predisposing causes, some patients experience tumor rupture due to external forces, such as trauma, delivery and tumor biopsy, while chemotherapy could induce tumor necrosis and might lead to altered blood flow to the capsule or surrounding tissue of the original tumor, resulting in coagulopathies that damage the tissue [11] . Since 2013, our institute has carried out core needle biopsy for NB patients. Thus far, this procedure has been performed in more than 500 cases. In the present study, only 7 cases of tumor rupture were caused by core needle biopsy (7/500, 1.4%). However, there were no significant differences of clinical characteristics and prognosis (except for age and INRG stage) between spontaneous and secondary (chemotherapy and core needle biopsy) NB rupture groups (Supplementary Table 2 ). Regarding the molecular biological characteristics of the tumor, 5 cases of spontaneously ruptured NB were reported in previous studies, and MYCN amplification was positive in 3 of 4 examined cases, suggesting that the aggressive behavior of MYCN-amplified NB might predispose the tumor to spontaneous rupture [1] .
As shown in
Previous studies have confirmed that MYCN gene amplification plays an important role in promoting angiogenesis and the proliferation, invasion, and metastasis of NB cells to inhibit cell differentiation and apoptosis [14] [15] [16] . Targeting MYCN has significant potential for the treatment of highly vascularized NB. The structure of blood vessels in malignant tumors was also considered fragile compared with that of blood vessels in normal tissues, which could cause the infarction of the vessels and the necrosis of the tumor capsule [16] .
The above molecular biological basis is helpful to explain the relationship between MYCN gene amplification and NB tumor rupture, but the specific mechanism still needs further study in the future.
The operative indication for spontaneous rupture of NB should be thoroughly considered.
Evaluating imaging-defined risk factors (IDRFs) plays an important role in judging whether upfront surgery can be performed. For stable patients with resectable tumors (without IDRFs), complete resection is the best choice to completely arrest the bleeding. In cases of unstable states or unresectable tumors (with IDRFs), interventional embolization or laparotomy for hemostasis as damage-control surgery might be applicable. Interventional embolization is an effective treatment for organ-origin tumors such as liver tumors and kidney tumors when spontaneous rupture occurs [17] [18] [19] [20] . However, NB originates from the retroperitoneum and usually has no definitive blood supply. Thus, interventional embolization was usually ineffective. Considering the imaging characteristics of the patients in this study, most of the ruptured NB tumors were huge. Additionally, the tumors always encased important intraperitoneal blood vessels, and seriously infiltrated adjacent organs or structures. Thus, IDRFs were present in most of the ruptured NBs, and upfront surgical resection was extremely difficult. In this study, 3 patients with spontaneously ruptured NB underwent upfront surgery. During the operation, we found that the tumors were huge, fragile and bled easily; they also seriously invaded the adjacent organs and blood vessels. Therefore, an appropriate surgical treatment must be discussed according to the patient's general state in addition to the tumor features (such as INRG staging, the origin, and local invasiveness). Exploration, hemostasis, and biopsy were the primary purpose if surgery was performed, and emergent removal of tumors was unnecessary when hemostasis was achieved.
In symptomatic support treatment, when a patient had a ruptured tumor, it was necessary to monitor the vital signs by ECG monitoring, recording urine volume, improving oxygenation by inhaling oxygen, correcting shock by intravascular fluid therapy, obtaining Alternatively, in extreme cases, evidence of histology could not be obtained in some patients who were highly clinically suspected of NB without bone marrow metastasis. As a 13 result, oncologists needed to communicate with the patients' parents that clinical diagnosis of NB and empirical chemotherapy were necessary to save the patients' lives.
However, when a patient is in stable condition, pathological histology and molecular biology tests should be performed as soon as possible to correct the NB staging and grouping. For preventing tumor lysis syndrome, adequate hydration and alkalization played important roles in controlling tumor burdens and improving the overall conditions of patients. For high-risk NB patients in very poor condition who could not tolerate highintensity chemotherapy, dose-induced chemotherapy could be performed in the first cycle of therapy, followed by standard protocols in the following cycles.
The results of this study showed that the prognosis of NB with tumor rupture was very poor. A few patients died directly due to MODS manifestations, such as hemorrhagic shock, heart failure, respiratory failure, and severe infection caused by tumor rupture.
However, most patients could be discharged in stable condition after symptomatic support treatment and chemotherapy and received further stratified treatment according to their risk grouping. Through intensive preoperative induction chemotherapy, the majority of patients' conditions were stabilized, the levels of tumor markers decreased, tumors shrank, and metastasis disease was relieved or disappeared. Patients usually had the opportunity for delayed surgery, but most patients were susceptible to progression or early recurrence. The median time of tumor progression or recurrence was 10 (6, 15) months in this study. Only one patient survived after tumor recurrence, whereas all other patients died. Researchers analyzed the clinical and prognostic information of 2266 patients with NB recurrence or progression in the INRG database [21] . The median time of NB progression or recurrence was 13.2 months. The median recurrence time of patients with MYCN amplification was 11 months in 562 cases and 14.5 months in 1141 patients with no MYCN amplification, with a significant difference between the two groups (P < 14 0.05). The 5-year overall survival (OS) rate of 2266 patients with recurrence was only 20% ± 1%, and patients who relapsed between 6 and 18 months after diagnosis had the highest risk of death (the peak value was approximately 12 months), which also supported the results of our study [21] . According to previous clinical studies, the most common recurrence sites in high-risk NB patients are bone and bone marrow, while the 5-year local recurrence rate of the primary site is only 11.9% ± 2.2% [22] . In this study, among 14 patients with disease progression or recurrence, 13 patients experienced intraperitoneal progression or recurrence, and these patients often presented with diffuse intraperitoneal lesions. These lesions strongly suggested that progression and recurrence were related to implant metastasis caused by tumor rupture.
Conclusions
Tumor rupture is an uncommon, life-threatening presentation among NB patients, and patients with ruptured NB are most likely to have a poor outcome due to rapid progression or recurrence of the tumor. Several treatment modalities, including symptomatic support therapy and chemotherapy with/without emergency surgery, are important for saving lives and creating the respective required conditions for subsequent NB risk-based treatment.
Additionally, the maximum diameter of primary tumor > 13.20 cm and MYCN gene amplification are two independent risk factors for high-risk NB tumor rupture. Thus, we can predict the early possibility of tumor rupture among NB patients and intervene as soon as possible, ultimately improving the prognosis of these patients.
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